VAFP
MRTX

Vahanian & Associates Financial Planning’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Vahanian & Associates Financial Planning’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,275
Closed -$230K – 64
2023
Q3 		$230K Buy
+5,275
New +$230K 0.74% 52